Table 2 Pre-admission treatment with psychiatric drugs among among critically ill patients with intellectual disability versus matched patients without intellectual disability
Study group with control (n = 174) % (n) | Study group (n = 58) % (n) | Control (n = 116) % (n) | p value | 95% CI | |
|---|---|---|---|---|---|
Yes | 27.6% (48) | 53.4% (31) | 14.7% (17) | < 0.001 | 0.06, 0.18 |
Antidepressants | 5.7% (10) | 12.1% (7) | 2.6% (3) | 0.017 | 0, 0.06 |
Typical antipsychotics | 4.6% (8) | 13.8% (11) | 0% (0) | < 0.001 | 0, 0 |
Atypical antipsychotics | 10.3% (18) | 20.7% (12) | 5.2% (6) | 0.002 | 0.01, 0.09 |
Benzodiazepines | 10.3% (18) | 20.7% (12) | 5.2% (6) | 0.002 | 0.01, 0.09 |
Mood stabilizers | 0.6% (1) | 0% (0) | 0.9% (1) | 1 | − 0.01, 0.03 |
Barbiturates | 1.1% (2) | 3.4% (2) | 0% (0) | 0.110 | 0, 0 |
Anti-convulsants | 15.5% (27) | 25.9% (15) | 10.3% (12) | 0.008 | 0.02, 0.12 |
Anticholinergics | 3.4% (6) | 8.6% (5) | 0.9% (1) | 0.008 | − 0.01, 0.03 |
Stimulants/psychoactives | 0.6% (1) | 1.7% (1) | 0% (0) | 0.333 | 0, 0 |